It is important to consult your healthcare provider before taking OMNICEF 125mg/5ml if you are pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your specific situation. Please note that the safety and suitability of OMNICEF 125mg/5ml during pregnancy or breastfeeding may depend on the active substance Cefdinir, concentration 125mg/5ml, and the specific recommendations of AL HIKMA PHARMACEUTICALS.